Healthy Johnson & Johnson Stock Going To $72
J&J?s decision to acquire Synthes for $21.3 billion will give a boost to revenues for DePuy division and improve market share in the spinal and orthopedic devices market.
Source: http://www.forbes.com/sites/greatspeculations/2012/03/02/healthy-johnson-johnson-stock-going-to-72/
get debt help government debt consolidation loans grants to pay off debt green path debt solutions